Abstract. Although matrix metalloproteinase-1 (MMP-1) has been considered a factor of crucial importance for breast cancer cells invasion and metastasis, the expression of MMP-1 in different breast cancer and cancer-adjacent tissues have not been fully examined. In the present study, immunohistochemical staining was used to detect the MMP-1 expression in non-specific invasive ductal carcinoma of the breast, cancer-adjacent normal breast tissue, lymph node metastatic non-specific invasive ductal carcinoma of the breast and normal lymph node tissue. The results showed that MMP-1 expression is different in the above tissues. MMP-1 had a positive expression in normal lymph node tissue and lymph node metastatic non-specific invasive ductal carcinoma. The MMP-1 negative expression rate was only 6.1% in non-specific invasive ductal carcinoma of the breast and 2.9% in cancer-adjacent normal breast tissue respectively. MMP-1 expression is higher in non-specific invasive ductal carcinoma and lymph node metastatic non-specific invasive ductal carcinoma compared to cancer-adjacent normal breast tissue and normal lymph node tissue. In conclusion, higher expression of MMP-1 in breast cancer may play a crucial role in promoting breast cancer metastasis.
Introduction
Breast cancer is a pathologically and clinically heterogeneous disease, and is the most frequent malignancy among females (1) . In addition, distant metastases are the most common type of breast cancer recurrence and are often the cause of fatality in breast cancer patients; metastases result in >40,000 fatalities per year in the USA alone (2) . In a previous study, it was demonstrated that most complications of breast cancer are attributed to metastasis to distant organs, including lymph nodes, bone, lung and liver (3) .
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endoproteinases that digest components of the extracellular matrix (ECM) and cell surface receptors for soluble factors and junctional proteins involved in cell-cell and cell-ECM interactions. Due to their matrix-degrading abilities and high expression in advanced tumors, MMP activity has been shown to be required for breast cancer cell invasion and angiogenesis (4, 5) . MMP-1, a member of the MMP family, is upregulated in breast cancer cell lines with an enhanced ability of tumor growth, invasion and distant metastasis (6, 7) . However, the expression of MMP-1 in breast cancer and cancer-adjacent tissues remains to be established. To address this issue, immunohistochemical staining was used to detect the MMP-1 expression in breast cancer and cancer-adjacent normal breast tissue. An extended understanding of the expression of MMP-1 may provide a novel insight into the role of MMP-1 in pathological process of breast tumorigenesis.
Materials and methods
Tissue microarray and immunohistochemical analysis. Tissue microarray purchased from Chaoying Bio-Technology Co., Ltd., (BR1002a; Xi'an, Shanxi, China). All the specimens had detailed information including age, gender, organization, pathological diagnosis, clinical grade, tumor-node-metastasis classification, clinical stage, specimen type and results.
Immunohistochemical analysis. To detect the expression of MMP-1, immunohistochemical staining was performed. Sections were heat-immobilized at 60˚C for 30 min and were deparaffinized in xylene and rehydrated through a series of graded ethanol solutions. Antigen retrieval was performed in a pressure cooker at 95˚C for 2 min using 0.01 M citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked by incubation with 3% hydrogen peroxide for 15 min at room temperature. Sections were subsequently incubated with anti-MMP-1 mouse monoclonal antibody (1:50; sc-21731; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 60 min at 37˚C in a humidified chamber. Subsequently, the sections were rinsed and incubated with a biotinylated secondary antibody for 30 min, followed by horseradish Matrix metalloproteinase-1 expression in breast cancer and cancer-adjacent tissues by immunohistochemical staining peroxidase-conjugated streptavidin for 30 min using the UltraSensitive™ Universal (anti-mouse/rabbit) Detection reagent (Fuzhou Maixin Biotechnology Development Co., Ltd., Fuzhou, China). Finally, the tissue microarray sections were stained with freshly prepared 3,3'-diaminobenzidine and counterstained lightly with hematoxylin. As a negative control, the primary antibody was replaced with normal rabbit or mouse immunoglobulin G at the same dilution. MMP-1 stain intensity was scored on a scale of 0 (negative) to 2 + (intense staining).
Results

Expression of MMP-1 in breast cancer and cancer-adjacent normal tissue.
The MMP-1 expression in breast cancer and cancer-adjacent normal tissue was detected by immunohistochemical staining. As shown in Table I , and Figs. 1 and 2, MMP-1 had a positive expression in normal lymph node tissue and lymph node metastatic non-specific invasive ductal carcinoma. MMP-1 had partially negative expression in non-specific invasive ductal carcinoma of the breast and cancer-adjacent normal breast tissue. The MMP-1 negative expression rate was only 6.1% in non-specific invasive ductal carcinoma of the breast and 2.9% in cancer-adjacent normal breast tissue, respectively.
MMP-1 expression is higher in non-specific invasive ductal carcinoma compared to cancer-adjacent normal breast tissue.
The MMP-1 expression rate in non-specific invasive ductal Normal lymph node tissue 9 0, 9, 0
Staining was scored using a 0-2 + scale. 0 means no staining; 1 + and 2 + indicate increased intensity of the staining. Sub-regions excluding necrosis, macrophages and infiltrated neutrophils and lymphocytes were selected and scored. The intensity score for an array spot is the average of all its sub-regions. carcinoma and cancer-adjacent normal breast tissue, lymph node metastatic non-specific invasive ductal carcinoma and normal lymph node tissue was analyzed. As shown in Table Ⅱ 
Discussion
MMPs are expressed in nearly all tumors, where they facilitate tumor growth, invasion and metastasis (4, 5) . The study by Kang et al (8) used microarray analysis to show that overexpression of MMP-1 enhances MDA-MB-231 cell bone metastasis. Additionally, in breast cancer, short hairpin RNA-mediated stable knockdown of MMP-1 or induction of MMP-1 by overexpression of δ-crystallin enhancer factor 1 significantly regulated the invasive ability of MDA-MB-231 (6,7). Since MMP-1 has been confirmed as a factor that facilitates breast cancer metastasis, the present study provides a novel discovery that MMP-1 expression is higher in non-specific invasive ductal carcinoma and lymph node metastatic non-specific invasive ductal carcinoma compared to cancer-adjacent normal breast tissue and normal lymph node tissue. The high expression of MMP-1 in breast cancer may be closely associated with its invasion and metastasis.
